MAPK3 and hepatocellular carcinoma: Interestingly, activating mutations in RAS and RAF genes, which are common genetic events that activate ERK1/2 pathway in other cancers, are rarely found in HCC.[32] Therefore, the continuous activation of ERK1/2 may rely more on external regulatory factors than internal genetic alterations.